Impact Solutions
USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A42B (HATS; Head Coverings).
The verdict
According to USPTO PatentsView, Impact ranks #47,628 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.
- #47,628
- of 49,997 US assignees by volume
- 40th percentile
- by Innovation Score (32.2/100)
- 17.8
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R47628 · US Corporation #47,628 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #47,628/49,997
- PHOTO-FINISH ImmunGene
- CPC-NARROW A42B · 6 areas
- INNOV-THIN 32.2/100
- CLAIMS-RICH 17.8 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: ImmunGene Inc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Impact’s 32.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Impact
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Impact Solutions · this assignee 32
Impact Solutions · this assignee
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Impact's Innovation Score is 32.2/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Impact?
Each dot is one of Impact’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Impact’s own 17.8 claims/patent is ABOVE the 13.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Impact's grants concentrate
Impact Solutions is a focused PatentsView assignee: 6 CPC subclasses with 60% of grants classified under A42B (HATS; Head Coverings). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2022. By volume, Impact sits between ImmunGene Inc and Inception Innovations, Inc..
Impact's three-year grant acceleration
Impact Solutions shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Impact's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Immungene
ImmunGene Inc
5 patents
- Immunomolecular T…
ImmunoMolecular Therapeutics, Inc.
5 patents
- Immunology Labora…
Immunology Laboratories, Inc.
5 patents
- Immy
Immy Inc.
5 patents
- In The Black Revo…
In The Black Revocable Trust
5 patents
- Intunes Products
InTunes Products, LLC
5 patents
- Incanthera
Incanthera Ltd
5 patents
- Inception Innovat…
Inception Innovations, Inc.
5 patents
- Impact Solutions ◀
Impact Solutions
5 patents
What this shows Impact holds 5 patents at rank #47,767, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Impact
By rank, the assignees closest to #47,767 in granted patent volume.
- ImmunGene Inc #47,763 · 5 patents
- ImmunoMolecular Therapeutics, Inc. #47,764 · 5 patents
- Immunology Laboratories, Inc. #47,765 · 5 patents
- Immy Inc. #47,766 · 5 patents
- In The Black Revocable Trust #47,768 · 5 patents
- InTunes Products, LLC #47,769 · 5 patents
- Incanthera Ltd #47,770 · 5 patents
- Inception Innovations, Inc. #47,771 · 5 patents
Leaders in A42B (HATS)
Other assignees with the most granted patents in Impact's primary technology class.
Impact's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 40th percentile higher than 40% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 2 | 40.0% |
| 2022 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
| 2025partial year | 1 | 20.0% |
Which technologies does Impact Solutions patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Impact Solutions's patent record in context - here's where to go next.
- Impact Solutions's lead technology class is A42B (HATS; Head Coverings), 60% of its portfolio - see every assignee active in that class. Explore A42B
- Ranked #47,628 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Impact Solutions against ImmunGene Inc, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.